UAB "BIOPHARMASPEC" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 0 |
| 0 |
| -276,142 |
| -276,142 |
| -116,516 |
| - |
| - |
| -275,142 |
| 594,800 |
| 77,303 |
| 242,355 |
| 2025 |
|---|
| 119,704 |
| 19,245 |
| -554,943 |
| -554,943 |
| -89,219 |
| -73.73 |
| -463.60 |
| -830,085 |
| 1,161,672 |
| 209,403 |
| 114,500 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 119,704 |
| 19,245 |
| -554,943 |
| -554,943 |
| -89,219 |
| -73.73 |
| -463.60 |
| -830,085 |
| 1,161,672 |
| 209,403 |
| 114,500 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
119,704 €- *
Sales per employee (€)
19,245 €- *
Profit before tax (€)
-554,943 €-101 % *
Net Profit (€)
-554,943 €-101 % *
Profit per employee (€)
-89,219 €23 % *
Total profitability (%)
-73.73 %- *
Net profitability (%)
-463.60 %- *
Equity (€)
-830,085 €-202 % *
Amounts Payable And Liabilities (€)
1,161,672 €95 % *
Non-current Assets (€)
209,403 €171 % *
CurrentAssets (€)
114,500 €-53 % *
